Status:
COMPLETED
The Role of Probiotics in Periodontal Disease
Lead Sponsor:
Gazi University
Conditions:
Periodontal Diseases
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
In this randomized controlled trial, it was aimed to evaluate the effect of probiotics (chewable tablets) and kefir consumption in the initial periodontal treatment of periodontitis patients on the ch...
Eligibility Criteria
Inclusion
- Systemically healthy
- Individuals over 18
- Periodontitis (4-6 mm pockets) patients with 3 teeth in each half of the jaws except wisdom tooth
- Non-smoker
- Not using probiotic tablets/capsules and consuming no more than 3-4 probiotic food.
Exclusion
- Antibiotic use within 6 months.
- Breastfeeding or pregnancy.
- Acute oral lesions or necrotizing ulcerative periodontitis
- Diabetes, rheumatic fever, lung, kidney disease history and drug use that will affect periodontal tissues
- Patients who smoke or who did not stop until last year
- Use of probiotics tablets or capsules
- Probiotic food consumption not more than 3-4 times a week
Key Trial Info
Start Date :
January 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 28 2021
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05211219
Start Date
January 7 2021
End Date
May 28 2021
Last Update
February 15 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Gazi University Faculty of Dentistry
Ankara, Turkey (Türkiye), 06490
2
Tuğba Şahin
Ankara, Turkey (Türkiye), 06560